Total Payments
$1,499
2023 Payments
$970.61
Companies
7
Transactions
24
Medicare Patients
469
Medicare Billing
$45,392
Payment Breakdown by Category
Food & Beverage$1,499 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,499 | 24 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Neurocrine Biosciences, Inc. | $854.35 | 12 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $229.37 | 3 | $0 (2019) |
| Sumitomo Pharma America, Inc. | $125.00 | 1 | $0 (2023) |
| Lilly USA, LLC | $120.44 | 4 | $0 (2019) |
| Teva Pharmaceuticals USA, Inc. | $84.87 | 1 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $45.90 | 1 | $0 (2023) |
| Avanir Pharmaceuticals, Inc. | $39.19 | 2 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $970.61 | 14 | Neurocrine Biosciences, Inc. ($714.84) |
| 2022 | $139.51 | 1 | Neurocrine Biosciences, Inc. ($139.51) |
| 2019 | $389.00 | 9 | Janssen Pharmaceuticals, Inc ($229.37) |
All Payment Transactions
24 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/07/2023 | Neurocrine Biosciences, Inc. | — | Food and Beverage | In-kind items and services | $133.91 | General |
| 10/24/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $45.90 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/02/2023 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $56.40 | General |
| Category: Neuropsychiatry | ||||||
| 03/28/2023 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $133.68 | General |
| Category: Neuropsychiatry | ||||||
| 03/28/2023 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $51.65 | General |
| Category: Neuropsychiatry | ||||||
| 03/27/2023 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $105.26 | General |
| Category: Neuropsychiatry | ||||||
| 03/27/2023 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $32.48 | General |
| Category: Neuropsychiatry | ||||||
| 02/02/2023 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $53.16 | General |
| Category: Neuropsychiatry | ||||||
| 01/31/2023 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $64.15 | General |
| Category: Neuropsychiatry | ||||||
| 01/31/2023 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $59.40 | General |
| Category: Neuropsychiatry | ||||||
| 01/31/2023 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $12.84 | General |
| Category: Neuropsychiatry | ||||||
| 01/30/2023 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $11.91 | General |
| Category: Neuropsychiatry | ||||||
| 01/18/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Urology | ||||||
| 01/17/2023 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $84.87 | General |
| Category: Central Nervous System | ||||||
| 09/20/2022 | Neurocrine Biosciences, Inc. | — | Food and Beverage | In-kind items and services | $139.51 | General |
| 08/13/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $117.91 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/12/2019 | Avanir Pharmaceuticals, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $24.99 | General |
| Category: pseudobulbar affect (PBA) | ||||||
| 07/23/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.15 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/28/2019 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $22.19 | General |
| Category: Diabetes | ||||||
| 05/14/2019 | Avanir Pharmaceuticals, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $14.20 | General |
| Category: pseudobulbar affect (PBA) | ||||||
| 04/23/2019 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $74.43 | General |
| Category: Diabetes | ||||||
| 04/23/2019 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $15.63 | General |
| Category: Diabetes | ||||||
| 04/23/2019 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $8.19 | General |
| Category: Diabetes | ||||||
| 02/13/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $97.31 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 1 | 12 | 12 | $2,688 | $328.44 |
| 2021 | 7 | 457 | 587 | $129,484 | $45,064 |
Total Patients
469
Total Services
599
Medicare Billing
$45,392
Procedure Codes
10
All Medicare Procedures & Services
10 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Office | 2022 | 12 | 12 | $2,688 | $328.44 | 12.2% |
| 99306 | Initial nursing facility visit, typically 45 minutes per day | Facility | 2021 | 192 | 200 | $69,719 | $25,103 | 36.0% |
| 99309 | Subsequent nursing facility visit, typically 25 minutes per day | Facility | 2021 | 47 | 79 | $15,064 | $5,427 | 36.0% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Facility | 2021 | 64 | 92 | $13,638 | $4,856 | 35.6% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Office | 2021 | 62 | 64 | $9,897 | $2,847 | 28.8% |
| 99305 | Initial nursing facility visit, typically 35 minutes per day | Facility | 2021 | 17 | 17 | $5,407 | $1,719 | 31.8% |
| 99439 | Chronic care management services, each additional 20 minutes of clinical staff time per calendar month | Office | 2021 | 21 | 58 | $4,930 | $1,568 | 31.8% |
| 99309 | Subsequent nursing facility visit, typically 25 minutes per day | Office | 2021 | 13 | 20 | $3,760 | $1,267 | 33.7% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time per calendar month | Office | 2021 | 21 | 37 | $3,589 | $1,150 | 32.0% |
| 99497 | Advance care planning by the physician or other qualified health care professional, first 30 minutes | Facility | 2021 | 20 | 20 | $3,480 | $1,126 | 32.4% |
About Dr. Darren Swenson, MD
Dr. Darren Swenson, MD is a Hospitalist healthcare provider based in Tacoma, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1942274170.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Darren Swenson, MD has received a total of $1,499 in payments from pharmaceutical and medical device companies, with $970.61 received in 2023. These payments were reported across 24 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($1,499).
As a Medicare-enrolled provider, Swenson has provided services to 469 Medicare beneficiaries, totaling 599 services with total Medicare billing of $45,392. Data is available for 2 years (2021–2022), covering 10 distinct procedure/service records.
Ad
Practice Information
- Specialty Hospitalist
- Other Specialties Internal Medicine
- Location Tacoma, WA
- Active Since 02/14/2006
- Last Updated 02/12/2018
- Taxonomy Code 208M00000X
- Entity Type Individual
- NPI Number 1942274170
Products in Payments
- INGREZZA (Drug) $580.93
- XARELTO (Drug) $229.37
- GEMTESA (Drug) $125.00
- TRULICITY (Drug) $120.44
- AUSTEDO (Drug) $84.87
- FARXIGA (Drug) $45.90
- NUEDEXTA (Drug) $39.19
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hospitalist Doctors in Tacoma
Dr. David Dempster, Md, MD
Hospitalist — Payments: $114,544
Hospitalist $114,544
Debapriya De, Md, MD
Hospitalist — Payments: $1,192
Hospitalist $1,192
Bruce Wilson, M.d, M.D
Hospitalist — Payments: $851.82
Hospitalist $851.82
Abhinav Agarwal, Md, MD
Hospitalist — Payments: $608.37
Hospitalist $608.37
Dr. Mary Storm, Md, MD
Hospitalist — Payments: $554.96
Hospitalist $554.96
Dr. Ali Thomas, M.d, M.D
Hospitalist — Payments: $466.78
Hospitalist $466.78